📣 For more lifestyle news, click here to join our WhatsApp Channel and also follow us on Instagram

The UK Health Service Agency (UKHSA) has designated a sub-variant of Omicron as a “variant under investigation”, saying that it is a level below the status of Omicron, marked a “variant of concern” by the WHO.
The stealth omicron is “a sub-lineage known as BA.2 of the dominant and highly transmissible Omicron coronavirus variant”, said Dr Mrinal Sircar, director oof Pulmonology and critical care at Fortis Hospital, Noida. “As per UKHSA, 40 countries had reported BA.2 sequences, with the most in Denmark, followed by India, Britain, Sweden and Singapore,” the expert added.
Agreed Dr Laxman Jessani, Consultant, Infectious Diseases, Apollo Hospitals Navi Mumbai, said that “In India we are already seeing this substrain in our genomic testing. The symptoms and treatment are same as other substrains, like BA.1. Also, the vaccine efficacy of BA.2 is also same as other sub variants.”
Both the experts confirmed that while the sub variant doesn’t escape an RT-PCR test, “the way the variant was confirmed was by seeing if there was a S gene drop out for BA.1. In BA.2, there is no S gene drop out, it would be difficult to confirm if it is BA.2 or some other variant without a full genome sequencing,” stated Dr Sircar.
Answering if the new variant is of concern, where it has already been detected amidst rising Covid-19 cases, Dr Sircar said, “A greater spread of any virus means potentially more mutations, which holds true for this variant as well.”
📣 For more lifestyle news, follow us on Instagram | Twitter | Facebook and don’t miss out on the latest updates!